![]() |
American
Ginseng
|
|
Interactions
withHerbs/Pharmaceuticals
|
|
|
Interactions with pharmaceuticals: None known for P.quinquefolius
3
Practitioners
should use caution when advising diabetics to take American ginseng
as it may significantly reduce their blood sugars thereby reducing their
need for hypoglycemic drugs. Theoretically,
American ginseng could interfere with antipsychotic drugs and monoamine
oxidase inhibiters (MAOIs).
15
There
have been some reports that ginseng can cause falsely elevated levels
of digoxin in patients being monitored for this cardiac glycoside, depending
on the immunoassay used. Clinicians
should be aware of this possibility before reducing digoxin dosage. There
is one preliminary report that Panax ginseng extracts can inhibit CYP3A4
activity in cultured human hepatocytes.
Clinicians should be aware of the potential for elevated plasma
levels of CYP3A4 substrates in patients taking ginseng until this report
is substantiated or refuted. There
are also sporadic reports of estrogenic effects of ginsenosides that
would make ginseng use unwise in breast cancer patients with ER-positive
disease.
|
|
| History and Traditional Use | Botanical Characteristics | ||
| Interactions withHerbs/Drugs/Disease | Adverse Effects/Contraindications | References | Ginkgo-Home |
| Information Sheets for Consumers |